Qingran Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qingran Kong has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Weibo Hou
8 shared publicationsMing Zong
7 shared publicationsQi Zhao
7 shared publicationsJiaming Zhang
6 shared publicationsSongling Xiao
6 shared publications- Zhonghua Liu
Key Laboratory of Animal Cellular and Genetics Engineering of Heilongjiang Province, College of Life Science, Northeast Agricultural University, Harbin 150030, China
6 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Elsevier in Trends Open
Metabolic regulation links signaling, epigenetics, and cellular plasticity during early embryogenesis
- 8 September 2026
- Published by Elsevier in Trends Open
Open AccessMetabolic regulation links signaling, epigenetics, and cellular plasticity during early embryogenesis
- Open Access
- 1 May 2026
- Published by KEAI Publishing in Fundamental Research
- Vol. 6 (3) , 1552-1565
Pre-implantation embryo metabolism identified by PEMA reveals endogenous lactate insufficiency contributes to pre-implantation development arrest
Metabolism is a major regulator of pre-implantation embryonic development, but pre-implantation development arrest (PIDA) due to abnormal metabolisms remains ambiguous. By estimating a weight for each metabolic reaction using the translatome data, we developed a computational tool to perform pre-implantation embryos metabolic analysis (PEMA), and uncovered that the embryos exist in high activities of lactate dehydrogenase and lactate synthesis when major zygotic genome activation (ZGA) occurs in humans and mice. The insufficiency of endogenous lactate was predicted by PEMA in human 8-cell PIDA and corrected human tripronuclear (ch3PN) embryos, which was coordinated with failed H3K18lac and major ZGA. In transcriptomes, the human PIDA embryos resembled endogenous lactate-deprived mouse embryos. Lac-CoA addition could promote H3K18lac, major ZGA, and ch3PN pre-implantation development. Collectively, our study decodes the metabolic abnormalities in human PIDA embryos. The experimental validation suggests that PEMA offers an opportunity to study metabolic heterogeneity in early embryos.
- 1 May 2026
- Published by KEAI Publishing in Fundamental Research
- Vol. 6 (3) , 1552-1565
Open AccessPre-implantation embryo metabolism identified by PEMA reveals endogenous lactate insufficiency contributes to pre-implantation development arrest
Metabolism is a major regulator of pre-implantation embryonic development, but pre-implantation development arrest (PIDA) due to abnormal metabolisms remains ambiguous. By estimating a weight for each metabolic reaction using the translatome data, we developed a computational tool to perform pre-implantation embryos metabolic analysis (PEMA), and uncovered that the embryos exist in high activities of lactate dehydrogenase and lactate synthesis when major zygotic genome activation (ZGA) occurs in humans and mice. The insufficiency of endogenous lactate was predicted by PEMA in human 8-cell PIDA and corrected human tripronuclear (ch3PN) embryos, which was coordinated with failed H3K18lac and major ZGA. In transcriptomes, the human PIDA embryos resembled endogenous lactate-deprived mouse embryos. Lac-CoA addition could promote H3K18lac, major ZGA, and ch3PN pre-implantation development. Collectively, our study decodes the metabolic abnormalities in human PIDA embryos. The experimental validation suggests that PEMA offers an opportunity to study metabolic heterogeneity in early embryos.
- Open Access
- 29 January 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1733391
Identification of small molecule inhibitors targeting FGFR through molecular docking-based screening
Background: FGFRs genetic alterations such as mutations, amplifications, and chromosomal translocations are prevalent in cancers, leading to the initiation and progression of tumors by enhancing FGFR signaling. The substantial problems arising from the lack of decisive clinical evidence have resulted in the cessation of some inhibitor applications, and identifying effective small molecule inhibitors that selectively target FGFRs can advance the therapy of cancers driven by FGFRs abnormalities. Methods: The three-dimensional structure of the FGFR1/2/3/4 protein and the amino acid positions within the tyrosine kinase domain were downloaded from the PDB database, and small molecule data were extracted from the ZINC15 database. Then, we used molecular docking and dynamics simulations to assess compounds interacting with FGFR proteins, and screening potential small molecules targeting FGFR. Finally, we evaluated its effects by two CRC cell line HCT116 and NCI-H716. Results: In the study, by docking with 2.8 million small molecules, we identified three promising FGFR small molecule inhibitors ranked in the top average absolute difference in free energy. By evaluating the binding stability of the docking pose of the three compounds, we found that ZINC000101867325 could form the stable binding interactions with FGFR1/2/3. And, ZINC000101867325 inhibited the activity of FGFR signaling, and resulted in cell apoptosis and decrease in cell proliferation and migration in colorectal cancer cell lines. In addition, ZINC000101867325 is also predicted to target FGFR2 mutations in colorectal cancer patients. Conclusion: We predicted three small molecules targeting FGFRs, and ZINC000101867325 shows superior chemical bond types and stability with FGFR1/2/3, and inhibits FGFR signaling in CRC cell lines. This study provides novel FGFRs inhibitors, which enrich treatment strategies for cancers.
- 29 January 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1733391
Open AccessIdentification of small molecule inhibitors targeting FGFR through molecular docking-based screening
Background: FGFRs genetic alterations such as mutations, amplifications, and chromosomal translocations are prevalent in cancers, leading to the initiation and progression of tumors by enhancing FGFR signaling. The substantial problems arising from the lack of decisive clinical evidence have resulted in the cessation of some inhibitor applications, and identifying effective small molecule inhibitors that selectively target FGFRs can advance the therapy of cancers driven by FGFRs abnormalities. Methods: The three-dimensional structure of the FGFR1/2/3/4 protein and the amino acid positions within the tyrosine kinase domain were downloaded from the PDB database, and small molecule data were extracted from the ZINC15 database. Then, we used molecular docking and dynamics simulations to assess compounds interacting with FGFR proteins, and screening potential small molecules targeting FGFR. Finally, we evaluated its effects by two CRC cell line HCT116 and NCI-H716. Results: In the study, by docking with 2.8 million small molecules, we identified three promising FGFR small molecule inhibitors ranked in the top average absolute difference in free energy. By evaluating the binding stability of the docking pose of the three compounds, we found that ZINC000101867325 could form the stable binding interactions with FGFR1/2/3. And, ZINC000101867325 inhibited the activity of FGFR signaling, and resulted in cell apoptosis and decrease in cell proliferation and migration in colorectal cancer cell lines. In addition, ZINC000101867325 is also predicted to target FGFR2 mutations in colorectal cancer patients. Conclusion: We predicted three small molecules targeting FGFRs, and ZINC000101867325 shows superior chemical bond types and stability with FGFR1/2/3, and inhibits FGFR signaling in CRC cell lines. This study provides novel FGFRs inhibitors, which enrich treatment strategies for cancers.
- 13 February 2025
- Published by Springer Nature in Science China Life Sciences
- Vol. 68 (5) , 1410-1422
Low-dose exposure to microplastics retards meiotic maturation via HDAC3 insufficiency
Microplastics (MPs) are considered one of the main causes of male and female infertility. However, the reproductive toxicity and its related mechanisms are currently understood primarily through animal models with acute exposure to MPs. In this study, we demonstrate that low-dose exposure to polystyrene microplastics (PSMPs) leads to severely abnormal reproduction in females, manifested by oocyte meiotic maturation defect. Mechanistically, PSMPs exposure induce the overactivation of cell metabolism pathways, insufficient HDACs, and H4K16 hyperacetylation in oocytes both in vivo and in vitro. When an HDAC3 inhibitor is added, the oocyte maturation defect, overactivation of cell metabolism pathways, and H4K16 hyperacetylation are recapitulated. Conversely, the overexpression of HDAC3 can rescue the defects in meiotic maturation induced by PSMPs. Our observations suggest a direct link between the maturation defects caused by PSMPs and HDAC3 insufficiency. Thus, we propose potential treatments to address the meiotic maturation defect of oocytes in women highly exposed to MPs by activating or supplying HDAC3.
- 13 February 2025
- Published by Springer Nature in Science China Life Sciences
- Vol. 68 (5) , 1410-1422
Low-dose exposure to microplastics retards meiotic maturation via HDAC3 insufficiency
Microplastics (MPs) are considered one of the main causes of male and female infertility. However, the reproductive toxicity and its related mechanisms are currently understood primarily through animal models with acute exposure to MPs. In this study, we demonstrate that low-dose exposure to polystyrene microplastics (PSMPs) leads to severely abnormal reproduction in females, manifested by oocyte meiotic maturation defect. Mechanistically, PSMPs exposure induce the overactivation of cell metabolism pathways, insufficient HDACs, and H4K16 hyperacetylation in oocytes both in vivo and in vitro. When an HDAC3 inhibitor is added, the oocyte maturation defect, overactivation of cell metabolism pathways, and H4K16 hyperacetylation are recapitulated. Conversely, the overexpression of HDAC3 can rescue the defects in meiotic maturation induced by PSMPs. Our observations suggest a direct link between the maturation defects caused by PSMPs and HDAC3 insufficiency. Thus, we propose potential treatments to address the meiotic maturation defect of oocytes in women highly exposed to MPs by activating or supplying HDAC3.
- Open Access
- 30 December 2024
- Published by Elsevier in Cell Reports
- Vol. 44 (1) , 115148
Acetylation at lysine 27 on maternal H3.3 regulates minor zygotic genome activation
- 30 December 2024
- Published by Elsevier in Cell Reports
- Vol. 44 (1) , 115148
Open AccessAcetylation at lysine 27 on maternal H3.3 regulates minor zygotic genome activation
- Open Access
- 23 April 2024
- Published by Springer Nature in Research Square
A novel long intergenic noncoding RNA indispensable for the formation of zygote in pig
Long noncoding RNAs (lncRNAs) are increasingly being recognized as modulators of mammalian early embryonic development. However, in pig, it is seldom investigated. In this study, lncRNAs were predicted using single-cell RNA-seq data on porcine early embryos from oocyte to early blastocyst. We further identified a novel nuclear long intergenic noncoding RNA (lincRNA),linc-321, which was specifically and highly expressed in 1-cell embryo, and it was indispensable for the formation of zygote and early embryonic development in pig. Its knockdown by locked nucleic acid (LNA)-siRNA could result in developmental arrest at 1-cell stage with failure of pronuclear envelope fusion (PEF). Mechanistically, linc-321 facilitates the recruitment of SUZ12 to the TSS region of MYT1. And this recruitment is instrumental in establishing H3K27me3 modifications, consequently leading to the repression of MYT1 expression. Moreover, the failure of PEF and developmental arrest induced by loss oflinc-321could be rescued by addition oflinc-321with LNA-siRNA targeting site deletion andMYT1knockdown. Thus, as functional lincRNA characterized in pig,linc-321provides the clues for investigating the strictly regulated process of early embryonic development.
- 23 April 2024
- Published by Springer Nature in Research Square
Open AccessA novel long intergenic noncoding RNA indispensable for the formation of zygote in pig
Long noncoding RNAs (lncRNAs) are increasingly being recognized as modulators of mammalian early embryonic development. However, in pig, it is seldom investigated. In this study, lncRNAs were predicted using single-cell RNA-seq data on porcine early embryos from oocyte to early blastocyst. We further identified a novel nuclear long intergenic noncoding RNA (lincRNA),linc-321, which was specifically and highly expressed in 1-cell embryo, and it was indispensable for the formation of zygote and early embryonic development in pig. Its knockdown by locked nucleic acid (LNA)-siRNA could result in developmental arrest at 1-cell stage with failure of pronuclear envelope fusion (PEF). Mechanistically, linc-321 facilitates the recruitment of SUZ12 to the TSS region of MYT1. And this recruitment is instrumental in establishing H3K27me3 modifications, consequently leading to the repression of MYT1 expression. Moreover, the failure of PEF and developmental arrest induced by loss oflinc-321could be rescued by addition oflinc-321with LNA-siRNA targeting site deletion andMYT1knockdown. Thus, as functional lincRNA characterized in pig,linc-321provides the clues for investigating the strictly regulated process of early embryonic development.
- 20 April 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-8
Maternal factor Trim75 contributes to zygotic genome activation program in mouse early embryos
Background Zygotic genome activation (ZGA) is an important event in the early embryo development, and human embryo developmental arrest has been highly correlated with ZGA failure in clinical studies. Although a few studies have linked maternal factors to mammalian ZGA, more studies are needed to fully elucidate the maternal factors that are involved in ZGA. Methods and results In this study, we utilized published single-cell RNA sequencing data from a Dux-mediated mouse embryonic stem cell to induce a 2-cell-like transition state and selected potential drivers for the transition according to an RNA velocity analysis. Conclusions An overlap of potential candidate markers of 2-cell-like-cells identified in this research with markers generated by various data sets suggests that Trim75 is a potential driver of minor ZGA and may recruit EP300 and establish H3K27ac in the gene body of minor ZGA genes, thereby contributing to mammalian preimplantation embryo development.
- 20 April 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-8
Maternal factor Trim75 contributes to zygotic genome activation program in mouse early embryos
Background Zygotic genome activation (ZGA) is an important event in the early embryo development, and human embryo developmental arrest has been highly correlated with ZGA failure in clinical studies. Although a few studies have linked maternal factors to mammalian ZGA, more studies are needed to fully elucidate the maternal factors that are involved in ZGA. Methods and results In this study, we utilized published single-cell RNA sequencing data from a Dux-mediated mouse embryonic stem cell to induce a 2-cell-like transition state and selected potential drivers for the transition according to an RNA velocity analysis. Conclusions An overlap of potential candidate markers of 2-cell-like-cells identified in this research with markers generated by various data sets suggests that Trim75 is a potential driver of minor ZGA and may recruit EP300 and establish H3K27ac in the gene body of minor ZGA genes, thereby contributing to mammalian preimplantation embryo development.
- Open Access
- 28 February 2024
- Published by Oxford University Press (OUP) in Life Metabolism
- Vol. 3 (2) , loae005
Lipidomic remodeling during mammalian preimplantation embryonic development
The dynamic changes in lipids during early embryonic development in mammals have not yet been comprehensively investigated. In a recent paper published in Nature Cell Biology, Jin Zhang et al. reported the dynamic lipid landscapes during preimplantation embryonic development in mice and humans. They highlight the crucial role of lipid unsaturation in regulating embryogenesis.
- 28 February 2024
- Published by Oxford University Press (OUP) in Life Metabolism
- Vol. 3 (2) , loae005
Open AccessLipidomic remodeling during mammalian preimplantation embryonic development
The dynamic changes in lipids during early embryonic development in mammals have not yet been comprehensively investigated. In a recent paper published in Nature Cell Biology, Jin Zhang et al. reported the dynamic lipid landscapes during preimplantation embryonic development in mice and humans. They highlight the crucial role of lipid unsaturation in regulating embryogenesis.
- Open Access
- 19 January 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (1) , 1-14
COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma
Copy number variations (CNVs) play a vital role in regulating genes expression and tumorigenesis. We explored the copy number alterations in early-stage lung adenocarcinoma using high-throughput sequencing and nucleic acid flight mass spectrometry technology, and found that 8q22.1-22.2 is frequently amplified in lung adenocarcinoma tissues. COX6C localizes on the region and its expression is notably enhanced that driven by amplification in lung adenocarcinoma. Knockdown of COX6C significantly inhibits the cell proliferation, and induces S-G2/M cell cycle arrest, mitosis deficiency and apoptosis. Moreover, COX6C depletion causes a deficiency in mitochondrial fusion, and impairment of oxidative phosphorylation. Mechanistically, COX6C-induced mitochondrial deficiency stimulates ROS accumulation and activates AMPK pathway, then leading to abnormality in spindle formation and chromosome segregation, activating spindle assemble checkpoint, causing mitotic arrest, and ultimately inducing cell apoptosis. Collectively, we suggested that copy amplification-mediated COX6C upregulation might serves as a prospective biomarker for prognosis and targeting therapy in patients with lung adenocarcinoma.
- 19 January 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (1) , 1-14
Open AccessCOX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma
Copy number variations (CNVs) play a vital role in regulating genes expression and tumorigenesis. We explored the copy number alterations in early-stage lung adenocarcinoma using high-throughput sequencing and nucleic acid flight mass spectrometry technology, and found that 8q22.1-22.2 is frequently amplified in lung adenocarcinoma tissues. COX6C localizes on the region and its expression is notably enhanced that driven by amplification in lung adenocarcinoma. Knockdown of COX6C significantly inhibits the cell proliferation, and induces S-G2/M cell cycle arrest, mitosis deficiency and apoptosis. Moreover, COX6C depletion causes a deficiency in mitochondrial fusion, and impairment of oxidative phosphorylation. Mechanistically, COX6C-induced mitochondrial deficiency stimulates ROS accumulation and activates AMPK pathway, then leading to abnormality in spindle formation and chromosome segregation, activating spindle assemble checkpoint, causing mitotic arrest, and ultimately inducing cell apoptosis. Collectively, we suggested that copy amplification-mediated COX6C upregulation might serves as a prospective biomarker for prognosis and targeting therapy in patients with lung adenocarcinoma.
- Top Cited PapersOpen Access
- 20 November 2023
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 11 (2) , nwad295
Lactate regulates major zygotic genome activation by H3K18 lactylation in mammals
Lactate is present at a high level in the microenvironment of mammalian preimplantation embryos in vivo and in vitro. However, its role in preimplantation development is unclear. Here, we report that lactate is highly enriched in the nuclei of early embryos when major zygotic genome activation (ZGA) occurs in humans and mice. The inhibition of its production and uptake results in developmental arrest at the 2-cell stage, major ZGA failure, and loss of lactate-derived H3K18lac, which could be rescued by the addition of Lac-CoA and recapitulated by overexpression of H3K18R mutation. By profiling the landscape of H3K18lac during mouse preimplantation development, we show that H3K18lac is enriched on the promoter regions of most major ZGA genes and correlates with their expressions. In humans, H3K18lac is also enriched in ZGA markers and temporally concomitant with their expressions. Taken together, we profile the landscapes of H3K18lac in mouse and human preimplantation embryos, and demonstrate the important role for H3K18lac in major ZGA, showing that a conserved metabolic mechanism underlies preimplantation development of mammalian embryos.
- 20 November 2023
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 11 (2) , nwad295
Top Cited PapersOpen AccessLactate regulates major zygotic genome activation by H3K18 lactylation in mammals
Lactate is present at a high level in the microenvironment of mammalian preimplantation embryos in vivo and in vitro. However, its role in preimplantation development is unclear. Here, we report that lactate is highly enriched in the nuclei of early embryos when major zygotic genome activation (ZGA) occurs in humans and mice. The inhibition of its production and uptake results in developmental arrest at the 2-cell stage, major ZGA failure, and loss of lactate-derived H3K18lac, which could be rescued by the addition of Lac-CoA and recapitulated by overexpression of H3K18R mutation. By profiling the landscape of H3K18lac during mouse preimplantation development, we show that H3K18lac is enriched on the promoter regions of most major ZGA genes and correlates with their expressions. In humans, H3K18lac is also enriched in ZGA markers and temporally concomitant with their expressions. Taken together, we profile the landscapes of H3K18lac in mouse and human preimplantation embryos, and demonstrate the important role for H3K18lac in major ZGA, showing that a conserved metabolic mechanism underlies preimplantation development of mammalian embryos.